ELV — Elevance Health, Inc.
Healthcare · ETF XLV · as of 2026-09-22
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products ...
Price & today
| Stock today | -1.68% |
| Sector ETF today | +0.52% |
| Residual (stock-specific) | -2.20% |
Sector correlation
| 20-day correlation with XLV | 0.25 |
| 60-day correlation with XLV | 0.17 |
| Status | normal |
Decoupling fires when 60d corr − 20d corr > 0.20: stock used to track its sector but the relationship has weakened recently.
Technicals
| 10 EMA | $409.84 |
| 20 EMA | $407.42 |
| 50 EMA | $400.58 |
| EMA stack | BULLISH |
| RSI(14) | 47.7 |
| 52-week high distance | -7.75% |
| 52-week low distance | +46.42% |
Signals
| Market F&G | 44.9 |
| Bull% | 13.8% |
| OVTLYR status | BUY (27d) |
| Sector rank | #516 |
| Next earnings | 2026-10-19 (BMO, 26d) |
MarketSmith metrics - our compute
What do these abbreviations mean?
- RS Rating
- - IBD-style relative strength vs SPY (weighted 3/6/9/12-mo). 70+ = leaders pool, 80+ = strong.
- ADR%
- - average daily range over 20 days. 4%+ = the fast movers the playbook prefers (selection order, not a gate).
- RMV (tight)
- - Relative Measured Volatility, 15 bars, scaled 0-100. <15 = tight coiled base (green), <35 moderate, high = loose/expanding - not a base right now.
- Ext (ATR>20EMA)
- - how many ATRs price sits above its 20-EMA. ≤1 = in value (green), >2 = extended/chasing (red) - prefer a pullback.
- Rel Vol
- - latest volume vs the 50-day average. 100% = normal; 140%+ = breakout confirmation.
- U/D 50d / 25d
- - up-day vs down-day volume over the window. 1.1+ = net accumulation (institutions buying); under 0.9 on the 25d = net selling.
- Accum/Dist 25d
- - heavy-volume up days vs heavy-volume down days in the last 25 sessions (close moved 0.2%+ on above-average volume). The institutional-participation footprint; 5+ distribution days = O'Neil caution line.
- LoD dist
- - close distance above the day low in % of ATR (100 = one full ATR off the low). High = strong close.
- Off/Above 52w
- - trend-template legs: within 25% of the 52-week high, at least 25% above the 52-week low.
- Trend 8/8
- - all 8 Minervini Trend Template criteria pass. Discovery floor, NOT an entry signal - entries come from the VCP pivot.
- Base len (VCP)
- - weeks since the VCP base started on the latest scan. 10wk+ bases carry the edge; short stacked bases test below random.
Fundamentals & valuation - reference, not entry inputs
Company data - context read, not entry inputs
Quarterly EPS - earnings acceleration
A dash in %Chg is deliberate: the year-ago figure was a loss, so a growth % would be meaningless. A dash in Sales means we have no revenue figure for that quarter - read it as a gap in our data, not as zero revenue.
| Quarter | EPS ($) | %Chg YoY | Sales ($M) | %Chg |
|---|---|---|---|---|
| Oct-24 | 8.37 | -7% | 45,106.0 | +5% |
| Jan-25 | 3.84 | -32% | 45,442.0 | +7% |
| Apr-25 | 11.97 | +12% | 48,891.0 | +15% |
| Jul-25 | 8.84 | -13% | 49,776.0 | +13% |
| Oct-25 | 6.03 | -28% | 50,711.0 | +12% |
| Jan-26 | 3.33 | -13% | 49,747.0 | +9% |
| Apr-26 | 12.58 | +5% | 50,181.0 | +3% |
| Jul-26 | 7.45 | -16% | 50,474.0 | +1% |
eps_actual (the figure MarketSmith/Deepvue show) - whether a given quarter is GAAP or excludes a one-off follows the filing, so it can sit either side of another vendor's number; AAPL's Oct-24 row, the Sep-2024 fiscal quarter, is $0.97 here - GAAP, including the EU tax charge - where TradingView's year implies $1.64 · Sales ($M) = SEC EDGAR quarterly revenue (fiscal Q4 derived as FY minus 9-mo) · quarter = report month · %Chg blank = prior-year base under $0.05 (not meaningful).Recent news - our DB (Finnhub + OVTLYR)
- Sep 22 · How Centene's Strong Cash Flow Is Reshaping Its Balance Sheet Zacks Investment Research
- Sep 20 · Tracking William Nygren's Harris Associates Portfolio - Q2 2026 Update SeekingAlpha
- Sep 20 · Elevance Health (ELV) Stock May Be Below Fair Value As Guidance Was Reaffirmed Yahoo
- Sep 18 · Dividend Champion, Contender, And Challenger Highlights: Week September 20 SeekingAlpha
- Sep 18 · Should You Buy CVS Stock For The Margin Aetna Is Rebuilding? Yahoo
- Sep 18 · 2 Surging Stocks on Our Watchlist and 1 We Brush Off Yahoo
- Sep 16 − Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year? Zacks Investment Research
- Sep 16 · The One Cost Line UnitedHealth Stock Has Not Caught Up To Yet Yahoo